Literature DB >> 19883580

Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels.

Bonnie E Lai1, Marcus H Henderson, Jennifer J Peters, David K Walmer, David F Katz.   

Abstract

Topical microbicide products are being developed for the prevention of sexually transmitted infections. These include vaginally-applied gels that deliver anti-HIV molecules. Gels may also provide partial barriers that slow virion diffusion from semen to vulnerable epithelium, increasing the time during which anti-HIV molecules can act. To explore the barrier function of microbicide gels, we developed a deterministic mathematical model for HIV diffusion through realistic gel distributions. We applied the model to experimental data for in vivo coating distributions of two vaginal gels in women. Time required for a threshold number of virions to reach the tissue surface was used as a metric for comparing different scenarios. Results delineated how time to threshold increased with increasing gel layer thickness and with decreasing diffusion coefficient. We note that for gel layers with average thickness > approximately 100 microm, the fractional area coated, rather than the gel layer thickness, was the primary determinant of time to threshold. For gel layers < approximately 100 microm, time to threshold was brief, regardless of fractional area coated. Application of the model to vaginal coating data showed little difference in time to threshold between the two gels tested. However, the protocol after gel application (i.e., with or without simulated coitus) had a much more significant effect. This study suggests that gel distribution in layers of thickness >100 microm and fractional area coated >0.8 is critical in determining the ability of the gel to serve as a barrier to HIV diffusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19883580      PMCID: PMC2770622          DOI: 10.1016/j.bpj.2009.08.010

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  48 in total

Review 1.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

Review 2.  Intravaginal gels as drug delivery systems.

Authors:  Mary Justin-Temu; Festo Damian; Renaat Kinget; Guy Van Den Mooter
Journal:  J Womens Health (Larchmt)       Date:  2004-09       Impact factor: 2.681

Review 3.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

Review 4.  A review of the physical and chemical properties of human semen and the formulation of a semen simulant.

Authors:  Derek H Owen; David F Katz
Journal:  J Androl       Date:  2005 Jul-Aug

5.  Microbicide trial screeches to a halt.

Authors:  Karen Honey
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

6.  A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding.

Authors:  Andrew J Szeri; Su Chan Park; Stéphane Verguet; Aaron Weiss; David F Katz
Journal:  Phys Fluids (1994)       Date:  2008-08-21       Impact factor: 3.521

7.  Interpreting properties of microbicide drug delivery gels: analyzing deployment kinetics due to squeezing.

Authors:  Sarah L Kieweg; David F Katz
Journal:  J Pharm Sci       Date:  2007-04       Impact factor: 3.534

8.  Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

Authors:  Stephanie Skoler-Karpoff; Gita Ramjee; Khatija Ahmed; Lydia Altini; Marlena Gehret Plagianos; Barbara Friedland; Sumen Govender; Alana De Kock; Nazira Cassim; Thesla Palanee; Gregory Dozier; Robin Maguire; Pekka Lahteenmaki
Journal:  Lancet       Date:  2008-12-06       Impact factor: 79.321

9.  Dextrin sulfate as a vaginal microbicide: randomized, double-blind, placebo-controlled trial including healthy female volunteers and their male partners.

Authors:  Naomi Low-Beer; Rhian Gabe; Sheena McCormack; Valerie S Kitchen; Charles J Lacey; Andrew J Nunn
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-01       Impact factor: 3.731

Review 10.  Avoiding the void: cell-to-cell spread of human viruses.

Authors:  Quentin Sattentau
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

View more
  13 in total

1.  Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion.

Authors:  Austen M Erickson; Bruce I Henry; John M Murray; Per Johan Klasse; Christopher N Angstmann
Journal:  Biophys J       Date:  2015-07-07       Impact factor: 4.033

Review 2.  Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.

Authors:  Justin L Madrigal; Roberta Stilhano; Eduardo A Silva
Journal:  Tissue Eng Part B Rev       Date:  2017-03-10       Impact factor: 6.389

3.  Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion.

Authors:  Alex Chen; Scott A McKinley; Simi Wang; Feng Shi; Peter J Mucha; M Gregory Forest; Samuel K Lai
Journal:  Biophys J       Date:  2014-05-06       Impact factor: 4.033

4.  Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.

Authors:  Bonnie E Lai; Anthony R Geonnotti; Michael G Desoto; David C Montefiori; David F Katz
Journal:  Antiviral Res       Date:  2010-08-13       Impact factor: 5.970

5.  Using modeling to help understand vaginal microbicide functionality and create better products.

Authors:  David F Katz; Yajing Gao; Meng Kang
Journal:  Drug Deliv Transl Res       Date:  2011-05-17       Impact factor: 4.617

6.  Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.

Authors:  Lara E Pereira; Tyana Singletary; Amy Martin; Chuong T Dinh; Frank Deyounks; Angela Holder; Janet McNicholl; Karen W Buckheit; Robert W Buckheit; Anthony Ham; David F Katz; James M Smith
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

7.  Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus.

Authors:  Timothy Wessler; Alex Chen; Scott A McKinley; Richard Cone; Gregory Forest; Samuel K Lai
Journal:  ACS Infect Dis       Date:  2015-10-17       Impact factor: 5.084

8.  In vivo optical imaging of human vaginal gel thickness distributions with a probe-based, dual-modality instrument.

Authors:  Tyler K Drake; Michael G DeSoto; Jennifer J Peters; Marcus H Henderson; Bonnie Thiele; Tammy Sinclair Bishop; Amy P Murtha; David F Katz; Adam Wax
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

9.  Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.

Authors:  E Fabian Cardozo; Rutao Luo; Michael J Piovoso; Ryan Zurakowski
Journal:  J Theor Biol       Date:  2013-12-28       Impact factor: 2.691

10.  Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1.

Authors:  Karen W Buckheit; Robert W Buckheit
Journal:  Mol Biol Int       Date:  2012-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.